Study of knee osteoarthritis with evaluation of safety and efficacy of Bozidan in its management.
Phase 2
- Conditions
- Health Condition 1: M170- Bilateral primary osteoarthritis of knee
- Registration Number
- CTRI/2021/03/032178
- Lead Sponsor
- Central council for research in Unani medicine New dehli
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically and radiologically diagnosed patients.
Kellgren and Lawrence grade 1,2 knee osteoarthritis.
Patients who agree to sign the informed consent.
Exclusion Criteria
Kellgren and Lawrence grade 3, 4 knee osteoarthritis.
pregnant and lactating women.
BMI greater than 35kg per meter square.
History of recent knee infection.
Previous knee surgery.
patients with rheumatoid arthritis.
patients with history of systemic disease like diabetes, cardiovascular,hypertension,impaired renal or hepatic function.
patients who refuse to give the written consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in signs and symptoms of primary knee osteoarthritis.Timepoint: 45 days
- Secondary Outcome Measures
Name Time Method heamatological and biochemical assessment for safetyTimepoint: 45 days